207 related articles for article (PubMed ID: 30067426)
1. iTRAQ-based quantitative proteomic analysis of differentially expressed proteins in chemoresistant nasopharyngeal carcinoma.
Wang K; Chen Z; Long L; Tao Y; Wu Q; Xiang M; Liang Y; Xie X; Jiang Y; Xiao Z; Yan Y; Qiu S; Yi B
Cancer Biol Ther; 2018; 19(9):809-824. PubMed ID: 30067426
[TBL] [Abstract][Full Text] [Related]
2. Identification of nasopharyngeal carcinoma metastasis-related biomarkers by iTRAQ combined with 2D-LC-MS/MS.
Chen Z; Long L; Wang K; Cui F; Zhu L; Tao Y; Wu Q; Xiang M; Liang Y; Qiu S; Xiao Z; Yi B
Oncotarget; 2016 Jun; 7(23):34022-37. PubMed ID: 27145374
[TBL] [Abstract][Full Text] [Related]
3. iTRAQ-Based Quantitative Proteomic Analysis of Nasopharyngeal Carcinoma.
Cai XZ; Zeng WQ; Xiang Y; Liu Y; Zhang HM; Li H; She S; Yang M; Xia K; Peng SF
J Cell Biochem; 2015 Jul; 116(7):1431-41. PubMed ID: 25648846
[TBL] [Abstract][Full Text] [Related]
4. Identification Keratin 1 as a cDDP-resistant protein in nasopharyngeal carcinoma cell lines.
Tang S; Huang W; Zhong M; Yin L; Jiang H; Hou S; Gan P; Yuan Y
J Proteomics; 2012 Apr; 75(8):2352-60. PubMed ID: 22348822
[TBL] [Abstract][Full Text] [Related]
5. Comparative Proteomic Profiling of Cisplatin-resistant Nasopharyngeal Carcinoma Cell Lines: Novel Biomarkers for Improving Chemotherapy of NPC.
Prathaphan P; Reamtong O; Ngaokrajang U; Janvilisri T; Swainson NM; Kiatwuthinon P
Anticancer Res; 2022 Jul; 42(7):3507-3522. PubMed ID: 35790268
[TBL] [Abstract][Full Text] [Related]
6. Proteome profiling of Epstein-Barr virus infected nasopharyngeal carcinoma cell line: identification of potential biomarkers by comparative iTRAQ-coupled 2D LC/MS-MS analysis.
Feng X; Zhang J; Chen WN; Ching CB
J Proteomics; 2011 Apr; 74(4):567-76. PubMed ID: 21296196
[TBL] [Abstract][Full Text] [Related]
7. FBW7 increases drug sensitivity to cisplatin in human nasopharyngeal carcinoma by downregulating the expression of multidrug resistance-associated protein.
Song Y; Zhou X; Bai W; Ma X
Tumour Biol; 2015 Jun; 36(6):4197-202. PubMed ID: 25586348
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the differential secretome of nasopharyngeal carcinoma cell lines CNE-2R and CNE-2.
Chen ZT; Li L; Guo Y; Qu S; Zhao W; Chen H; Su F; Yin J; Mo QY; Zhu XD
Oncol Rep; 2015 Nov; 34(5):2477-88. PubMed ID: 26352878
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA‑122 acts as tumor suppressor by targeting TRIM29 and blocking the activity of PI3K/AKT signaling in nasopharyngeal carcinoma in vitro.
Yang Y; Li Q; Guo L
Mol Med Rep; 2018 Jun; 17(6):8244-8252. PubMed ID: 29693120
[TBL] [Abstract][Full Text] [Related]
10. Quantitative proteomic analysis of formalin-fixed and paraffin-embedded nasopharyngeal carcinoma using iTRAQ labeling, two-dimensional liquid chromatography, and tandem mass spectrometry.
Xiao Z; Li G; Chen Y; Li M; Peng F; Li C; Li F; Yu Y; Ouyang Y; Xiao Z; Chen Z
J Histochem Cytochem; 2010 Jun; 58(6):517-27. PubMed ID: 20124091
[TBL] [Abstract][Full Text] [Related]
11. [Establishment of a human nasopharyngeal carcinoma drug-resistant cell line CNE2/DDP and screening of drug-resistant genes].
Jiang RD; Zhang LX; Yue W; Zhu YF; Lu HJ; Liu X; Cen XT; Guan XY; Li CH
Ai Zheng; 2003 Apr; 22(4):337-45. PubMed ID: 12703984
[TBL] [Abstract][Full Text] [Related]
12. Identification of candidate biomarkers for the early detection of nasopharyngeal carcinoma by quantitative proteomic analysis.
Yang J; Zhou M; Zhao R; Peng S; Luo Z; Li X; Cao L; Tang K; Ma J; Xiong W; Fan S; Schmitt DC; Tan M; Li X; Li G
J Proteomics; 2014 Sep; 109():162-75. PubMed ID: 24998431
[TBL] [Abstract][Full Text] [Related]
13. Quantitative proteome analysis identifies MAP2K6 as potential regulator of LIFR-induced radioresistance in nasopharyngeal carcinoma cells.
Li Z; Fu J; Li N; Shen L
Biochem Biophys Res Commun; 2018 Oct; 505(1):274-281. PubMed ID: 30245131
[TBL] [Abstract][Full Text] [Related]
14. Nasopharyngeal Carcinoma Protein Interaction Mapping Analysis via Proteomic Approaches.
Zamanian Azodi M; Rezaei Tavirani M; Rezaei Tavirani M; Vafaee R; Rostami-Nejad M
Asian Pac J Cancer Prev; 2018 Mar; 19(3):845-851. PubMed ID: 29582644
[TBL] [Abstract][Full Text] [Related]
15. NEDD4 is involved in acquisition of epithelial-mesenchymal transition in cisplatin-resistant nasopharyngeal carcinoma cells.
Feng S; Yang G; Yang H; Liang Z; Zhang R; Fan Y; Zhang G
Cell Cycle; 2017 May; 16(9):869-878. PubMed ID: 28379054
[TBL] [Abstract][Full Text] [Related]
16. Identification of differential proteins in nasopharyngeal carcinoma cells with p53 silence by proteome analysis.
Sun Y; Yi H; Zhang PF; Li MY; Li C; Li F; Peng F; Feng XP; Yang YX; Yang F; Xiao ZQ; Chen ZC
FEBS Lett; 2007 Jan; 581(1):131-9. PubMed ID: 17184779
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of NFBD1/MDC1 enhances chemosensitivity to cisplatin or 5-fluorouracil in nasopharyngeal carcinoma CNE1 cells.
Zeng Q; Wang Z; Liu C; Gong Z; Yang L; Jiang L; Ma Z; Qian Y; Yang Y; Kang H; Hong S; Bu Y; Hu G
Mol Cell Biochem; 2016 Jul; 418(1-2):137-46. PubMed ID: 27334757
[TBL] [Abstract][Full Text] [Related]
18. FOXC2 promotes chemoresistance in nasopharyngeal carcinomas via induction of epithelial mesenchymal transition.
Zhou Z; Zhang L; Xie B; Wang X; Yang X; Ding N; Zhang J; Liu Q; Tan G; Feng D; Sun LQ
Cancer Lett; 2015 Jul; 363(2):137-45. PubMed ID: 25896630
[TBL] [Abstract][Full Text] [Related]
19. Epithelial-mesenchymal transition is necessary for acquired resistance to cisplatin and increases the metastatic potential of nasopharyngeal carcinoma cells.
Zhang P; Liu H; Xia F; Zhang QW; Zhang YY; Zhao Q; Chao ZH; Jiang ZW; Jiang CC
Int J Mol Med; 2014 Jan; 33(1):151-9. PubMed ID: 24173500
[TBL] [Abstract][Full Text] [Related]
20. Enhancer remodeling activates NOTCH3 signaling to confer chemoresistance in advanced nasopharyngeal carcinoma.
Liu L; Deng P; Liu S; Hong JH; Xiao R; Guan P; Wang Y; Wang P; Gao J; Chen J; Sun Y; Chen J; Mai HQ; Tan J
Cell Death Dis; 2023 Aug; 14(8):513. PubMed ID: 37563118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
